Literature DB >> 15282359

Beyond fast track for drug approvals.

Thomas G Roberts1, Bruce A Chabner.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15282359     DOI： 10.1056/NEJMsb040064

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Economic evaluations in the canadian common drug review.

Authors:  Andreas Laupacis
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  The politics and bio-ethics of regulatory trust: case-studies of pharmaceuticals.

Authors:  John Abraham
Journal:  Med Health Care Philos       Date:  2008-07-22

3.  Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?

Authors:  Elizabeth A Richey; E Alison Lyons; Jonathan R Nebeker; Veena Shankaran; June M McKoy; Thanh Ha Luu; Narissa Nonzee; Steven Trifilio; Oliver Sartor; Al B Benson; Kenneth R Carson; Beatrice J Edwards; Douglas Gilchrist-Scott; Timothy M Kuzel; Dennis W Raisch; Martin S Tallman; Dennis P West; Steven Hirschfeld; Antonio J Grillo-Lopez; Charles L Bennett
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

Review 4.  In the end what matters most? A review of clinical endpoints in advanced breast cancer.

Authors:  Sunil Verma; Deanna McLeod; Gerald Batist; André Robidoux; Ilídio R S Martins; John R Mackey
Journal:  Oncologist       Date:  2011-01-06

5.  Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension.

Authors:  A K Doran; D D Ivy; R J Barst; N Hill; S Murali; R L Benza
Journal:  Int J Clin Pract Suppl       Date:  2008-07

Review 6.  Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis.

Authors:  Linda S Elting; Yu-Chia Chang; Pratibha Parelkar; Christine B Boers-Doets; Marisol Michelet; Guido Hita; Tanya Rouleau; Catherine Cooksley; Josiah Halm; Madhuri Vithala; Paolo Bossi; Carmen Escalante; Michael T Brennan
Journal:  Support Care Cancer       Date:  2013-05-02       Impact factor: 3.603

Review 7.  Drug development in advanced colorectal cancer: challenges and opportunities.

Authors:  Robin Kelley; Alan P Venook
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

8.  Biomedical journal editing: elements of success.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; George D Kitas
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

9.  Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures.

Authors:  G Apolone; R Joppi; V Bertele'; S Garattini
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.